National Trial Attorney ROSEN Encourages Fulgent Genetics, Inc.

National Trial Attorney ROSEN Encourages Fulgent Genetics, Inc.

Facebook
Twitter
LinkedIn

NEW YORK, Oct. 4, 2022 (GLOBE NEWSWIRE) — Why:Rosen Law Firm, a global investor rights law firm, is reminding you to acquire Fulgent Genetics, Inc. (NASDAQ: FLGT) during the period of March 22, 2019 through August 4, 2022, both dates inclusive (the “Class Period”). Buyers of securities are remindedNovember 21, 2022 is the lead plaintiff’s deadlineImportant day.

What:If you purchased Fulgent Genetics stock during a class action lawsuit, you may be entitled to compensation without paying out-of-pocket expenses or costs incurred under contingency fee arrangements.

Next Step:To participate in the Fulgent Genetics fundraiser, go to https://rosenlegal.com/submit-form/?case_id=8809 Or call Mr. Phillip Kim toll free: 866-767-3653 or email:[email protected] or [email protected] Learn more about class action lawsuits. A class action lawsuit has been filed. If you wish to be a lead plaintiff, you must do so Apply to the court by November 21, 2022. Lead Plaintiff is the representative who directs the proceeding on behalf of the other members of the class.

Why choose ROSEN LAW:We recommend investors to select qualified legal advisors with a successful track record in senior positions. Often, the law firm issuing the notice does not have comparable experience, resources, or meaningful peer recognition.Many of these law firms do not actually conduct securities class actions, but are merely intermediaries referring clients or working with the law firm that actually files the lawsuit.Be wise when choosing a lawyer. The Law Firm of Rosen represents global investors with a focus on securities class action lawsuits and shareholder derivatives lawsuits. Law firm Rosen reaches the largest-ever settlement in a securities class action lawsuit against a Chinese company. In 2017, ISS Securities Class Action Services ranked Rosen Law Firm #1 for the number of securities class action settlements. The company has ranked in the top four every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company recovered more than $438 million for investors. In 2020 founding partner Laurence Rosen was appointed by Law360…

Continue to read on GlobeNewswire https://www.globenewswire.com/news-release/2022/10/04/2527486/673/zh-hant/%E5%9C%8B%E5%AE%B6%E5%AF%A9%E5%88%A4%E5%BE%8B%E5%B8%AB-ROSEN-%E9%BC%93%E5%8B%B5-Fulgent-Genetics-Inc-%E6%8A%95%E8%B3%87%E8%80%85%E5%9C%A8%E8%AD%89%E5%88%B8%E9%9B%86%E9%AB%94%E8%A8%B4%E8%A8%9F%E7%9A%84%E9%87%8D%E8%A6%81%E6%88%AA%E6%AD%A2%E6%97%A5%E6%9C%9F%E5%89%8D%E5%B0%8B%E6%B1%82%E6%B3%95%E5%BE%8B%E6%84%8F%E8%A6%8B-FLGT.html

More to explorer